Differences between revisions 2 and 4 (spanning 2 versions)
Revision 2 as of 2006-11-15 22:18:35
Size: 2601
Editor: lfrq80
Comment:
Revision 4 as of 2006-11-17 21:22:35
Size: 2644
Editor: lfrq80
Comment:
Deletions are marked like this. Additions are marked like this.
Line 1: Line 1:
## page was renamed from SaveBioPax
Line 7: Line 8:
|| '''Use Case Name''' : SaveBioPax || || '''Use Case Name''' : ../SaveBioPax ||
Line 47: Line 48:
Shared MimEditorUseCaseComments ../Shared MimEditorUseCaseComments

Use Case Name : ../SaveBioPax

For Feature : self:MIMEditor

Editors: DavidKane

TableOfContents([2])

Summary

A user wants to save a BioPax representation of a map.

Step-by-Step User Action

  1. User has edited a map
  2. The user specifies that the map is to be saved
  3. The systems writes out an appropriate BioPax repressentation

Visual Aides

Requirements for Cytoscape

TBD

Importance

Many pathway repositories are moving towards adopting BioPax as a standard of exchange. If the Kohn maps are exchangeable as BioPax, they could be exchanged and used more widely.

Other Examples

Comments

../Shared MimEditorUseCaseComments

It is not clear if saving as BioPax should be part of how the maps are normally saved, or if BioPax should be a “Save As” option. It is also not clear how to pair the visualization layout information with the BioPax representation.

PageComment2

Molecular_Interaction_Maps/SaveBioPax (last edited 2009-02-12 01:03:41 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux